
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion
Junli Lu, Yiming Luo, Dean Rao, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 31
Junli Lu, Yiming Luo, Dean Rao, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 31
Showing 1-25 of 31 citing articles:
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 2
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 2
Leveraging Single-Cell Multi-Omics to Decode Tumor Microenvironment Diversity and Therapeutic Resistance
Hussein Sabit, Borros Arneth, Timothy M. Pawlik, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 75-75
Open Access | Times Cited: 1
Hussein Sabit, Borros Arneth, Timothy M. Pawlik, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 75-75
Open Access | Times Cited: 1
Tumor battlefield within inflamed, excluded or desert immune phenotypes: the mechanisms and strategies
Siwei Zheng, Wenwen Wang, Lesang Shen, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Siwei Zheng, Wenwen Wang, Lesang Shen, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Recent Treatment Strategies and Molecular Pathways in Resistance Mechanisms of Antiangiogenic Therapies in Glioblastoma
Md. Ataur Rahman, Meser M. Ali
Cancers (2024) Vol. 16, Iss. 17, pp. 2975-2975
Open Access | Times Cited: 7
Md. Ataur Rahman, Meser M. Ali
Cancers (2024) Vol. 16, Iss. 17, pp. 2975-2975
Open Access | Times Cited: 7
Targeted modulation of myeloid-derived suppressor cells in the tumor microenvironment: Implications for cancer therapy
Yafeng Qi, Liying Zhang, Y Q Liu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117590-117590
Closed Access | Times Cited: 5
Yafeng Qi, Liying Zhang, Y Q Liu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117590-117590
Closed Access | Times Cited: 5
Circular RNAs: key players in tumor immune evasion
Mahla Sanati, Soudeh Ghafouri‐Fard
Molecular and Cellular Biochemistry (2025)
Closed Access
Mahla Sanati, Soudeh Ghafouri‐Fard
Molecular and Cellular Biochemistry (2025)
Closed Access
Myeloid-derived suppressor cells exhibit distinct characteristics in bone marrow and blood of individuals with diffuse large B-cell lymphoma
Paris Efstratiou, Athina Damianaki, Aglaia Kavidopoulou, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
Paris Efstratiou, Athina Damianaki, Aglaia Kavidopoulou, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
Chimeric Antigen Receptor Cell Therapy: Empowering Treatment Strategies for Solid Tumors
Tang‐Her Jaing, Yi-Wen Hsiao, Yi-Lun Wang
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 2, pp. 90-90
Open Access
Tang‐Her Jaing, Yi-Wen Hsiao, Yi-Lun Wang
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 2, pp. 90-90
Open Access
The colorectal cancer microenvironment: Preclinical progress in identifying targets for cancer therapy
Abdo Meyiah, Faez Iqbal Khan, Dia Aldeen Alfaki, et al.
Translational Oncology (2025) Vol. 53, pp. 102307-102307
Open Access
Abdo Meyiah, Faez Iqbal Khan, Dia Aldeen Alfaki, et al.
Translational Oncology (2025) Vol. 53, pp. 102307-102307
Open Access
Unravelling the role of ubiquitin-specific proteases in breast carcinoma: insights into tumour progression and immune microenvironment modulation
Huiyuan Yang, Tingting Sun, Zhenni Sun, et al.
World Journal of Surgical Oncology (2025) Vol. 23, Iss. 1
Open Access
Huiyuan Yang, Tingting Sun, Zhenni Sun, et al.
World Journal of Surgical Oncology (2025) Vol. 23, Iss. 1
Open Access
Click chemistry-based modified exosomes: Towards enhancing precision in cancer theranostics
Nobendu Mukerjee, Swastika Maitra, Mandeep Kaur, et al.
Chemical Engineering Journal (2025), pp. 160915-160915
Closed Access
Nobendu Mukerjee, Swastika Maitra, Mandeep Kaur, et al.
Chemical Engineering Journal (2025), pp. 160915-160915
Closed Access
Tumor-infiltrating myeloid cells; mechanisms, functional significance, and targeting in cancer therapy
Fatemeh Sadat Toghraie, Maryam Bayat, Mahsa Sadat Hosseini, et al.
Cellular Oncology (2025)
Open Access
Fatemeh Sadat Toghraie, Maryam Bayat, Mahsa Sadat Hosseini, et al.
Cellular Oncology (2025)
Open Access
Breast Cancer and Tumor Microenvironment: The Crucial Role of Immune Cells
Tânia Moura, Paula Laranjeira, Olga Caramelo, et al.
Current Oncology (2025) Vol. 32, Iss. 3, pp. 143-143
Open Access
Tânia Moura, Paula Laranjeira, Olga Caramelo, et al.
Current Oncology (2025) Vol. 32, Iss. 3, pp. 143-143
Open Access
Myeloid-derived suppressor cells in metabolic and cardiovascular disorders
Jingsheng Yan, Shuai Guo, Jun He, et al.
Trends in Endocrinology and Metabolism (2025)
Closed Access
Jingsheng Yan, Shuai Guo, Jun He, et al.
Trends in Endocrinology and Metabolism (2025)
Closed Access
Dual roles of myeloid-derived suppressor cells in various diseases: a review
Mahesh R. Nepal, S. P. Shah, Kyu‐Tae Kang
Archives of Pharmacal Research (2024) Vol. 47, Iss. 7, pp. 597-616
Closed Access | Times Cited: 3
Mahesh R. Nepal, S. P. Shah, Kyu‐Tae Kang
Archives of Pharmacal Research (2024) Vol. 47, Iss. 7, pp. 597-616
Closed Access | Times Cited: 3
Predictive Biomarkers and Resistance Mechanisms of Checkpoint Inhibitors in Malignant Solid Tumors
Luciana Alexandra Pavelescu, Robert Mihai Enache, Oana Alexandra Roşu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9659-9659
Open Access | Times Cited: 3
Luciana Alexandra Pavelescu, Robert Mihai Enache, Oana Alexandra Roşu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9659-9659
Open Access | Times Cited: 3
The roles of cancer stem cell-derived secretory factors in shaping the immunosuppressive tumor microenvironment in hepatocellular carcinoma
Gregory Kenneth Muliawan, Terence K. Lee
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Gregory Kenneth Muliawan, Terence K. Lee
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Unveiling the Dynamic Interplay between Cancer Stem Cells and the Tumor Microenvironment in Melanoma: Implications for Novel Therapeutic Strategies
Patrízia Limonta, Raffaella Chiaramonte, Lavinia Casati
Cancers (2024) Vol. 16, Iss. 16, pp. 2861-2861
Open Access | Times Cited: 2
Patrízia Limonta, Raffaella Chiaramonte, Lavinia Casati
Cancers (2024) Vol. 16, Iss. 16, pp. 2861-2861
Open Access | Times Cited: 2
Myeloid-Derived Suppressor Cells and Macrophage Polarization in Cancer Immunotherapy
Mohammad‐Salar Hosseini, Mohammad Amin Akbarzadeh, Farhad Jadidi‐Niaragh
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 157-204
Closed Access | Times Cited: 2
Mohammad‐Salar Hosseini, Mohammad Amin Akbarzadeh, Farhad Jadidi‐Niaragh
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 157-204
Closed Access | Times Cited: 2
NK/DC crosstalk-modulating antitumor activity via Sema3E/PlexinD1 axis for enhanced cancer immunotherapy
Awais Ali, Abdulaziz Alamri, Azraida Hajar
Immunologic Research (2024)
Closed Access | Times Cited: 2
Awais Ali, Abdulaziz Alamri, Azraida Hajar
Immunologic Research (2024)
Closed Access | Times Cited: 2
Overcoming immunosuppression in cancer: how ketogenic diets boost immune checkpoint blockade
Victoria E. Stefan, Daniela D. Weber, Roland Lang, et al.
Cancer Immunology Immunotherapy (2024) Vol. 74, Iss. 1
Open Access | Times Cited: 1
Victoria E. Stefan, Daniela D. Weber, Roland Lang, et al.
Cancer Immunology Immunotherapy (2024) Vol. 74, Iss. 1
Open Access | Times Cited: 1
Frontiers in pancreatic cancer on biomarkers, microenvironment, and immunotherapy
Baofa Yu, Shengwen Shao, Wenxue Ma
Cancer Letters (2024), pp. 217350-217350
Open Access | Times Cited: 1
Baofa Yu, Shengwen Shao, Wenxue Ma
Cancer Letters (2024), pp. 217350-217350
Open Access | Times Cited: 1
CD24a knockout transforms the tumor microenvironment from cold to hot by promoting tumor-killing immune cell infiltration in a murine triple-negative breast cancer model
Shih‐Hsuan Chan, Hsuan-Jung Tseng, Lu‐Hai Wang
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Shih‐Hsuan Chan, Hsuan-Jung Tseng, Lu‐Hai Wang
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
The NF-κB1/p50 Subunit Influences the Notch/IL-6-Driven Expansion of Myeloid-Derived Suppressor Cells in Murine T-Cell Acute Lymphoblastic Leukemia
Behnaz Abdollahzadeh, Noemi Martina Cantale Aeo, Nike Giordano, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9882-9882
Open Access
Behnaz Abdollahzadeh, Noemi Martina Cantale Aeo, Nike Giordano, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9882-9882
Open Access
Optimising CAR T therapy for the treatment of solid tumors
Norhan Mobark, Caroline Hull, John Maher
Expert Review of Anticancer Therapy (2024), pp. 1-17
Open Access
Norhan Mobark, Caroline Hull, John Maher
Expert Review of Anticancer Therapy (2024), pp. 1-17
Open Access